News und Analysen
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023
Pfizer Posted a Steep Loss. Is It Time to Sell?
It's been about a couple of weeks since Pfizer (NYSE: PFE) promised to make Halloween extra spooky by warning us that third-quarter results would be disappointing.
It turns out the warning was more
Pfizer (PFE) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Pfizer (NYSE: PFE)Q3 2023 Earnings CallOct 31, 2023, 10:00 a.m. ET
Operator
Source Fool.com
Why Sarepta Therapeutics Stock Is Crashing Today
Shares of Sarepta Therapeutics (NASDAQ: SRPT) were crashing 43.6% lower as of 11:10 a.m. ET on Tuesday. The huge sell-off came after the company announced top-line results from its phase 3 Embark
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?
Big pharmas have the resources to make big, multi-year moves that can reshape or even redefine their businesses. As you may know, Merck (NYSE: MRK) is one of the largest of the big pharmas, with a
Pfizer's Coming for AbbVie's Market Share. Here's What It Means for Investors
On Oct. 13, regulators at the Food and Drug Administration (FDA) ruled that Pfizer's (NYSE: PFE) new drug for moderate to severe ulcerative colitis (UC), Velsipity, was ready for prime time. That
Humana Repeats as U.S. News & World Report’s Best Overall Medicare Advantage Plan Company for Second Year in a Row
For the second year in a row, U.S. News & World Report recognized leading health and well-being company Humana Inc. (NYSE: HUM) as the 2024 Best Insurance Company for Medicare Advantage in three
Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move
There are many things you can buy with $1,000, but most won't multiply your wealth over time. Investing in equity markets remains one of the best options. Buying shares of great companies and
Is AbbVie Still a Good Dividend Stock to Buy?
One thing income seekers don't want to see from the businesses they invest in is a major disruption to their incoming cash flows. Unfortunately for shareholders of AbbVie (NYSE: ABBV), the
Why AbbVie Stock Was a Winner on Monday
Pharmaceutical company AbbVie (NYSE: ABBV) was a cure for the investor blues on Monday. Shares of the company rose more than 2% in price on an analyst's recommendation upgrade. AbbVie stock's
Why Revvity Stock Plunged Today
Shares of Revvity (NYSE: RVTY) -- formerly known as PerkinElmer -- fell 16.1% on Monday after the health science solutions and services company announced weaker-than-expected third-quarter 2023
2 No-Brainer Dividend Stocks to Buy This Week
Dividend stocks can be consistent market-beaters. However, empirical research shows that the best dividend stocks tend to generate better-than-average returns because of their underlying value
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Healthcare companies are spending big on developing treatments for inflammatory bowel disease (IBD), which consists of either Crohn's disease or ulcerative colitis (UC), or both. The lure for IBD
3 No-Brainer Stocks to Buy for Under $100 Right Now
Benjamin Franklin would probably be disappointed that the $100 bill that bears his likeness isn't worth what it used to be. However, there are actually plenty of great stocks to be found that you
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
Sometimes, the old financial adages are spot on. For example, it does take money to make money. And the expression that "time is money" is correct in many ways.
But it's also true that some
Why AbbVie Stock Fell Today
Shares of AbbVie (NYSE: ABBV) were down 5.4% as of 2:00 p.m. ET Friday, even after the pharmaceuticals giant announced slightly better-than-expected quarterly results and raised its full-year
AbbVie (ABBV) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
AbbVie (NYSE: ABBV)Q3 2023 Earnings CallOct 27, 2023, 9:00 a.m. ET
Operator
Source Fool.com
2 Green Flags and 1 Red Flag for Novartis Stock
Share prices of Swiss pharmaceutical company Novartis (NYSE: NVS) have climbed more than 10% so far this year. The company focuses on cardiovascular, immunology, neuroscience, solid tumors, and
DexCom (DXCM) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
DexCom (NASDAQ: DXCM)Q3 2023 Earnings CallOct 26, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Merck (MRK) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q3 2023 Earnings CallOct 26, 2023, 9:00 a.m. ET
Operator
Source Fool.com
Beat the Dow Jones With UnitedHealth Group Stock
If you want to beat the market, the key is having strong stocks in your portfolio of businesses that are profitable and growing. One name that has routinely outperformed the markets is health
2 Best Healthcare Stocks to Buy Right Now
The healthcare industry may not be as hot with investors as artificial intelligence or other high-flying industries, but the range of essential needs these businesses serve provides opportunities
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
While equity markets this year have recovered some of ground lost from the plunge of 2022, plenty of companies are still struggling. Some of them, though, clearly have the tools to rebound
3 Pharma Stocks That Are Screaming Buys in October
It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD). Shares of all three healthcare companies are trading flat or down amid
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
Investing in healthcare can be an excellent way to focus on stable, long-term growth opportunities. And many top healthcare stocks also pay dividends. Two of the best healthcare stocks to buy right